IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 12,232,326 (75%) | — | ₹52,354 Cr |
| NII (HNI) | — | 2,446,464 (15%) | — | ₹10,471 Cr |
| Retail | — | 1,630,976 (10%) | — | ₹6,981 Cr |
| Σ Total | — | 16,309,766 (100%) | — | ₹698,058 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 33 | ₹14,124 |
| Retail (Max) | 13 | 429 | ₹183,612 |
| S-HNI (Min) | 14 | 462 | ₹197,736 |
| B-HNI (Min) | 67 | 2,211 | ₹946,308 |
Financial Statements Amount in ₹ Crore
| Metric | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 118 | 195 | 164 |
| Profit After Tax | 23 | 25 | -4 |
| Net Worth | 67 | 45 | 19 |
| Total Assets | 158 | 135 | 97 |
| Total Borrowing | 41 | 42 | 31 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by the Company. –
- Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings. –
- Funding the capital expenditure requirements for purchasing new machinery for the Company. –
- Investment in our subsidiary, Bizdent Devices Private Limited, is needed for the capital expenditure requirements for the purchase of new machinery. –
- General corporate purposes. –
Company Overview
Incorporated in July 2004, Laxmi Dental Limited is an integrated dental products company. The company offers custom crowns and bridges, branded dental items like clear aligners and thermoforming sheets, aligner-related products as part of its aligner solutions, and pediatric dental products.
Their product portfolio includes custom crowns and bridges, clear aligners, thermoforming sheets, pediatric dental products, and more.
The company offers thermoforming sheets, biocompatible 3D printing resins, and machines for manufacturing clear aligners under the brand name Taglus.
The company operate a fully integrated model, meaning they handle the entire process from design and manufacturing to distribution of dental products.
As of September 30, 2024, the company has six manufacturing facilities: three in Mira Road, Mumbai, two in Boisar, and one in Kochi, along with five supporting facilities in Mumbai, Delhi, Bengaluru, and Ahmedabad.
As of September 30, 2024, the company’s dental network includes over 22,000 clinics and dentists across more than 320 cities nationwide.
The company has significant presence in both domestic and international markets, exporting to over 90 countries.
As of September 30, 2024, the company had 2,372 employees in various departments.
Competitive strengths
- The only integrated dental products company in India, well-positioned to capture industry tailwinds;
- Second largest player in domestic laboratory business and largest export laboratory with increasing adoption of digital dentistry;
- Vertically integrated diverse branded product portfolio;
- Large Dental Network provide a competitive advantage in the market;
- Robust technologically advanced capabilities with stringent regulatory compliance ensuring high quality standards.